Detalhe da pesquisa
1.
Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect.
Haematologica
; 107(4): 909-920, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34109776
2.
ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease.
Int J Mol Sci
; 22(9)2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067041
3.
Aspartate ß-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3ß crosstalk.
Carcinogenesis
; 41(9): 1246-1252, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525968
4.
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production.
J Transl Med
; 11: 108, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23634660
5.
SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation.
Cells
; 12(4)2023 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831331
6.
Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities?
Hemasphere
; 7(3): e845, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36844186
7.
Xanthohumol impairs human prostate cancer cell growth and invasion and diminishes the incidence and progression of advanced tumors in TRAMP mice.
Mol Med
; 18: 1292-302, 2012 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22952060
8.
Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab.
J Immunother Cancer
; 10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543375
9.
The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability.
Mol Cancer
; 9: 142, 2010 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20537156
10.
Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy.
Cancers (Basel)
; 12(7)2020 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668783
11.
Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy.
Cells
; 9(3)2020 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32168749
12.
On arsenic and plague.
Clin Infect Dis
; 59(12): 1806-8, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25182246
13.
Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals.
Int J Cancer
; 125(9): 1997-2003, 2009 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19551861
14.
Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype.
Recent Results Cancer Res
; 181: 71-6, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19213559
15.
Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation.
Mol Cancer Ther
; 7(9): 2692-702, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18790751
16.
Human Gut-Associated Natural Killer Cells in Health and Disease.
Front Immunol
; 10: 961, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31130953
17.
The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants.
Int J Cancer
; 123(8): 1770-8, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18661523
18.
Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications.
Mol Cancer Ther
; 6(1): 286-98, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17237288
19.
Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.
ChemMedChem
; 13(19): 2119-2131, 2018 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30102846
20.
Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells.
Oncoimmunology
; 7(5): e1421889, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29721369